Edge Rewrite
everything Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a40f4b572ee52a7e

Jump to content

International Federation of Pharmaceutical Manufacturers & Associations

From Wikipedia, the free encyclopedia
(Redirected from IFPMA)
International Federation of Pharmaceutical Manufacturers & Associations
AbbreviationIFPMA
Formation1968
TypeTrade association
HeadquartersGeneva, Switzerland
President
Dr Thomas Schinecker, CEO, Roche Group
Key people
Dr Thomas Schinecker (President) Dr David Reddy (Director General)
Websitehttps://www.ifpma.org/

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)[1] is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations[2] where it contributes industry expertise to global health discussions.

It was formed in 1968 and is based in Geneva, Switzerland.[3]

In 2019, IFPMA released a strengthened code of ethics[4] and professional standards.[5] Among the revisions to the code is a prohibition on gifts provided to healthcare professionals.[6] The code revision has been followed by Ethoscope[7] – an open-source, continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments.

The pharmaceutical industry contributes to the Sustainable Development Goals (SDGs), in particular Goal 3 to ensure healthy lives and promote well-being for all at all ages.[8] Today over 35 IFPMA member companies contribute resources and know-how to SDG initiatives [9] partnering with academia, development organizations, NGOs, foundations and other business sectors. There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access.[10]

IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage (UHC).[11] It provides a platform for stakeholders to collaborate to increase access to essential medicines, low-cost effective interventions, and screenings.[12]

Leadership

[edit]

The President of IFPMA is Dr Thomas Schinecker, CEO, Roche Group. Robert M. Davis, Chairman and CEO of Merck & Co., and Hiroyuki Okuzawa, President and CEO, Daiichi Sankyo, serve as Vice-Presidents.[13]

See also

[edit]

References

[edit]
  1. ↑ "International Federation of Pharmaceutical Manufacturers & Associations - IFPMA". Retrieved 2 November 2023.
  2. ↑ "List of NGOs accredited at the UN Office at Geneva". Retrieved 7 December 2022.
  3. ↑ "About IFPMA". Archived from the original on 26 June 2014. Retrieved 11 Jun 2014.
  4. ↑ "New International Pharmaceutical Practice Code Tightens Restrictions on Gifts". Ropes & Gray. 27 February 2019. Retrieved 30 October 2023.
  5. ↑ Underwood, George (18 Mar 2020). "Industry and patient groups collaborate on new guidance for interaction". Retrieved 7 December 2022.
  6. ↑ Baker, Berry (20 December 2018). "IFPMA launches new Code of Practice for the pharmaceutical industry". Pharma Technology. Retrieved 30 October 2023.
  7. ↑ Lugogo, Mwana (24 April 2023). "Industry and patient groups collaborate on new guidance for interaction". PharmaBoardroom. Retrieved 30 October 2023.
  8. ↑ "Goal 3: Ensure healthy lives and promote well-being for all at all ages". United Nations. Retrieved 30 October 2023.
  9. ↑ Explore Collaborations Global Health Progress 2023, https://globalhealthprogress.org/explore-our-collaborations/
  10. ↑ "Global Health Progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the SDGs". 18 Mar 2022. Retrieved 7 December 2022.
  11. ↑ "Private Sector Commitments To Universal Health Coverage, UHC2030 Private Sector Constituency 2023 Statement" (PDF). UHC2030. Retrieved 30 October 2023.
  12. ↑ "The Road to 2030: Revitalizing Multi-sectoral Partnerships to Achieve Universal Health Coverage". Foreign Policy Analytics. Retrieved 30 October 2023.
  13. ↑ "Roche CEO named as new president of IFPMA". www.thepharmaletter.com. Retrieved 2024-11-27.
  14. ↑ EFPIA, https://www.ifpma.org/members/efpia/
  15. ↑ Interpharma, https://www.ifpma.org/members/interpharma/
  16. ↑ IPASA, https://www.ifpma.org/members/ipasa/
  17. ↑ JPMA, https://www.ifpma.org/members/jpma/
  18. ↑ LEEM, https://www.ifpma.org/members/leem/
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=International_Federation_of_Pharmaceutical_Manufacturers_%26_Associations&oldid=1367716178"